28,153
Participants
Start Date
March 31, 2012
Primary Completion Date
June 30, 2016
Study Completion Date
June 30, 2016
Immediate ARV treatment initiation with TDF/FTC/EFV
"All HIV-infected adults will be offered ART regardless of their immunological and clinical staging.~The first line regimen proposed will be Atripla (R), a fixed dose combination containing tenofovir disoproxil (245 mg)/emtricitabine (200 mg)/efavirenz (600 mg)(FTC/TDF/EFV). The dosing will be 1 tablet OD."
South African recommendation guided ARV (TDF/FTC/EFV) initiation
"HIV-infected adult participants will be eligible for ART as per the South African guidelines (August 2011) if:~* CD4 count ≤ 350 cells/mm3 irrespective of clinical symptoms~* WHO clinical stage 3 or 4 irrespective of CD4 count~* MDR or XDR TB The first line regimen proposed will be Atripla (R), a fixes dose combination containing tenofovir disoproxil (245 mg)/emtricitabine (200 mg)/efavirenz (600 mg)(TDF/FTC/EFV). The dosing will be 1 tablet OD."
Hlabisa Hospital, Hlabisa
Africa Centre For Health and Population Studies
OTHER
University of KwaZulu
OTHER
ANRS, Emerging Infectious Diseases
OTHER_GOV